BMRN regulatory event: an FDA approval, +6.4%

On August 26, 2021, Voxzogo — BioMarin Pharmaceutical Inc. (Achondroplasia) reached its regulatory event. The result was an FDA approval, and the stock moved +6.4% in the window around the event. It had already run -5.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.